Early Treatment of Rituximab Combined With Eltrombopag for Secondary Thrombocytopenic Purpura in Rheumatoid Arthritis

Early Treatment of Rituximab Combined With Eltrombopag for Secondary Thrombocytopenic Purpura in Rheumatoid Arthritis

header-info
Study investigators report a case of refractory ITP in which changes in platelet-related markers with therapeutic agents are worthy of the attention of clinicians.